Pure Global: Malaysia & Thailand's MedTech Dossier - The Hidden Hurdles.

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to basket failed.

Please try again later

Add to wishlist failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Unfollow podcast failed

Pure Global: Malaysia & Thailand's MedTech Dossier - The Hidden Hurdles.

Listen for free

View show details

About this listen

This week, we dive into the new "Med-Tech Unity Dossier," a pilot program launched by Malaysia and Thailand to streamline medical device registration. This episode unpacks what this move towards harmonization really means for manufacturers. We explore the massive opportunities for faster market access and the hidden complexities that lie beneath the surface. We'll discuss the practical challenges companies may face, from localized requirements to post-market surveillance, providing the insights you need to navigate this new regulatory frontier. A MedTech company is ready to launch its new Class C device in both Malaysia and Thailand. The new "Unity Dossier" promises a faster, unified path to market. But as a pilot program, the rules are new and untested. Do they risk being a guinea pig for the new system, potentially facing unforeseen delays and questions from regulators? Or do they stick with the two separate, predictable, but much slower traditional registration pathways? This is the strategic dilemma many now face. Key Takeaways: - What are the exact device classes eligible for the Med-Tech Unity Dossier pilot program? - How will the unified review process be coordinated between Malaysia's MDA and Thailand's FDA? - What are the hidden differences in local requirements, like labeling and language, that remain? - Does the Unity Dossier affect the need for separate in-country Authorized Representatives? - How will post-market surveillance and adverse event reporting be handled across both countries? - What are the potential timeline advantages compared to separate submissions? - What are the biggest risks for companies that join the pilot program early? At Pure Global, we offer end-to-end regulatory consulting to help you navigate precisely these kinds of challenges. Our local expertise in both Malaysia and Thailand, combined with advanced AI and data tools, can streamline your access to these markets. Let us help you turn regulatory complexity into a competitive advantage. Contact us at info@pureglobal.com or visit https://pureglobal.com/.

No reviews yet